Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Shawn, who would even use fluticare in October, November, or December? Dr.Damaje is a real @hole. I heard the reason why he's out of town, is because he's vacationing with our stolen money. The OTC nasal spray ship has already sailed, no FDA approval for INNV and Flonase and Clarispray have already won out anyway.
Is Damaje a dumbo? Or I guess I am, for getting on on this Titanic of a boat anchor.
Unfortunately, Honeycomb has almost always been wrong, mostly due to him being way too overly optimistic. I'm sorry Honey, I wish you and your MOAP were accurate. Honey, thus far, you've costed me another $14,000 dollar loss. I only hope we can recoup some money in bankruptcy litigation. I hope they don't lock up Damaj, I want him to at least be working as a bus boy, so we can have his wages garnished.
Shawn, in that case, I'll bet you that Damaje even dilutes his own piss and drinks it up, slurp, slurp, gulp.
Would anyone like to outline a list of all of INNV/Damaje mistakes?
1. Over promising on sales.
2. Under delivering on sales.
3. Claiming he put his own money into INNV without admitting he's being paid a lot interest as INNVs main creditor.
4. Not advertising on digital media and not advertising on radio.
5. Spending too much advertising money on an old medium, newspapers.
6. Over hyping fluticare multiple times.
7. Stuttering when he's been "cornered" on conference calls.
8. Diluting the stock to the point of it being worthless.
9. A debt offering of stock at .15 when it should have been offered higher.
10. Lying about how he got Apricus pharma to $6 per share (it was due to his several reverse splits.)
11. Saying no dilution coming on the Q4 call, then 3 days later diluting.
12. Saying fluticare was fast tracked for July 2017 and then saying it will be sold in December after the allergy season.
13. Selling snake oil/sugar pills.
14. Not getting repeat customers.
15. Ugly and hard to understand.
16. Doing the quarterly calls from some sort of a cheap, embarrassing, underground bunker.
17. A questionable "odor" or "aroma" coming from him.
Dr.Damaj over promised and under delivered. I guess it's good that Q1 2017 was better than Q1 2016, but geeze the operating expenses keep going up and the dilution and the slow and corrupted FDA. INNV has so many people to pay (including Damaj himself) that even if he could get fluticare to market in July, would there even be enough margin left for any profit? One article said fluticare would be fast tracked and now it won't be sold until December 2017? How is that fast tracked? Why bother with a backdoor way to sell Fluticare sooner when the FDA has until 12/31/17 to approve the original fluticare ANDA? It's amazing how this was hyped and went to .66 and now the hype is out of this balloon, much like a used condom.
It was indicated that Fluticare would be sold in the 4th quarter of this year, does that mean October, November and/or December?
I thought INNV could start selling Fluticare in the 2nd half of this year, in Q2, with this new shakey deal?
It seems to me that INNV and me are screwed for a while, a couple of years, or perhaps indefinitely?
Does anyone remember how people thought that INNV would have a trading halt, if/when Fluticare received FDA OTC approval? What a joke that was, GSK didn't have a trading halt after Flonase, nor did Bayer or Perrigo, or Costco.
Some of the wind has been taken out of this Fluticare sales work around, because it contains a middle man (according to one of the articles.)
Since the INNV share price hasn't moved up with this Fluticare announcement, maybe it won't move up at all, even after or if/when the original ANDA is approved?
It appears to me that the FDA is intentionally dragging their feet on the original ANDA Fluticare approval, due to corruption and GSK and Bayer probably paying them bribes under the table, to squash INNV.
It's amazing how the Fluticare hype approval boosted the share price up in the past, but now since it was already talked about so many times, it's like crying wolf and now it doesn't seem to matter much anymore.
From here on out, the main way to get the PPS up now is probably through sales, not through hype.
Please, no more dilution or crazy reverse splits.
Batermere, I wish I could take you up on the offer, but I'm not in the area, thanks though.
Honeycomb, keep in mind that repeat customers are almost as important as new customers, if not more important. Also, why would someone or anyone but Prostagorx at full price, when they could buy an Rx like Proscar or Avodart for a $5dollar copay with insurance?
INNV needs to advertise on Google and digital media as well, not just newspapers.
I am not a basher and I appreciate your posts and I want INNV to be successful. I am 65% down on a giant investment I made a while ago and thus far, averaging down hasn't helped me much yet.
Good luck to all and God Bless.
Well Shawn, that's a very unfortunate, possibility regrading fluticare. However, INNV already has the rights (supposedly) to fluticare and I don't think they'll give up on it. If fluticare bombs out, it would be more likely due to a paperwork filing error only discovered after 3 years of waiting, resulting in another 3 years of waiting.
When or if fluticare is approved, it could result in a different surprise, like it not increasing the share price at all, or it actually lowering the share price, due to the cost of manufacturing, production, advertising and/or it could actually result in more and dilution and an r/s as well.
I don't know for a fact that Damaj did an r/s at Apricus to raise it to $6, I just took it for granted based on what another poster said. However, I don't see a major difference between dilution or an r/s, because they both result in a lower share price, depending on how you look at it.
In one case, you have the same number of shares at a lower price and in the other case, you have less shares at a higher price, either way with a dilution or an r/s, the result is similar in that investors are f'd in the short to mid-term.
It would be really sad, if the thing most hoped for (fluticare approval) resulted in the PPS going way down, or the A/S going way up, or the costs going way, way up. (As they say, be careful what you wish for, you just might get it.)
JClue, yes and let's not forget Damaj brought Apricus pharma to $6 per share, moreso due to reverse splits, rather than increased sales or increases profits.
A message board observation;
Honeycomb and Healthywelth and are a bit too optimistic. A couple of key points is that INNV can't be compared to a GSK for a variety or reasons, nutra vs.pharma, etc. INNV can't be compared to some of the other smaller companies, because Honey didn't take into account the reverse splits. Damaj hasn't lost any money on INNV stock per say, because it's only a paper loss and not an actual realized loss, plus Damaj is an INNV creditor and has been paying himself interest.
Honeycomb and Healthywelth are not entirely wrong though and it's good to be positive, but it's just not good to be overly optimistic.
ShawnP123 and TrueTrades are a bit too negative, but they do make several realstic points that we and Honeycomb and Healthywelth need to take into account, such as; INNV can't be compared to some of the other smaller companies, because Honey didn't take into account the reverse splits. Damaj hasn't lost any money on INNV stock per say, because it's only a paper loss and not an actual realized loss, plus Damaj is an INNV creditor and has been paying himself interest.
An accurate assesment of INNV is really a combination of what Honeycomb, Healthywelth, Shawn and Truetrades have posted.
This is not meant to discount other posters that have contributed valid points.
Shawn, thanks for the Costco info, but I already new that. I don't use minoxidil liquid/spray, because the propylene glycol in it, causes scalp/skin itching. I use minoxidil foam and melt it into a liquid in the microwave (for quick application) and since it doesn't contain propylene glycol, no skin itching/irritation occurs. In the past, I used a custom liquid formula that didn't contain the propylene glycol, but the FDA took Dr.Lee's formula off the market.
Anyway, my point is not to buy they cheapest, but to get a good price on something effective. INNV indicated at one time, that it was involved with dermatology products, which is what minoxidil is considered, because it deals with hair and hair and skin are in the same medical category, dermatology.
I would gladly pay a few dollars more than Costco's price, just to support INNV, so Dr.Damaj, start selling Minoxidil!
A legitimate new product idea for INNV. I'm not saying that this would be a game changer, but maybe INNV should sell online, Minoxidil for men and women. If INNV had their customers buying their products primarily online (which increases the profit margin) and those customers bought routinely bought more than 1 product, that would be cool.
For the past 25years, I've been buying and using Rogaine/Minoxidil twice daily. Within the past couple of years, I switched to start using generic Minoxidil foam, which isn't smelly or greasy, I melt the foam in my microwave and then apply its' liquid form with a dropper onto my head, so INNV should market and sell a generic form of Minoxidil foam.
I think INNV should also sell natural mood enhancers, like kava kava, st.johns wart and lithium orotate.
Also, sell a natural sleeping pill that contains melatonin.
From INNV, I would buy minoxidil foam, melatonin sleeping pill, vessle boner pill and even though I don't have allergies, maybe even fluticare, if it helped me breather easier.
Interesting how INNV advertises heavily in newspaper print and not online or radio. Hopefully, fluticare will get approved and will be advertised heavily online, because as stated in an INNV interview, marketing directly to the customer results in a higher profit margin, than selling fluticare only in retail stores...
To: DrMonkeyGay, Hi-tech Akorn is the Fluticare manufacturer, proof;
Some have said a perfect storm of good news is possible, Q1 sales being met or being exceeded, fluti approval and even a European deal made.
However, it could just as easily be a perfect storm of bad news...Q1 sales not being met, no fluti approval and no European deal.
Unfortunately, my bet is that, it will be negative for a long, long time to come, up to an including, massive dilution, massive reverse splits, followed by dormancy and finally bankruptcy.
I don't have allergies, but I'm so frustrated, should I buy some flonase, just out of sheer anger and frustration?
How low will INNV go? Will it be .05 or even .001? If so, who would be a buyer? I guess it would depend on why it went down, poor sales, no fluti approval, no euro deal, more dilution?
Information to ponder...
"Innovus Pharmaceuticals, Inc. engages in the commercialization, licensing, and development of non-prescription medicine, and consumer care products for health and vitality, and respiratory diseases. It also provides packaged healthcare solutions through over-the-counter, medicines and consumer and health products, which it market directly or through commercial partners to primary care physicians, urologists, gynecologists and therapists, and directly to consumers through on-line channels, retailers and wholesalers. The company business model leverages the ability to acquire and in-license commercial products that are supported by scientific, and or clinical evidence, place them through it existing supply chain, retail and on-line channels. The company was founded on January 15, 1959 and is headquartered in San Diego, CA. "
1. Did you notice the multiple typos in the above article? (You can find that article on marketwatch.)
2. Notice how the article focuses on mistakenly explaining flubbed up "distribution channels" and not on explaining the actual products and growth for the future.
3. Notice how the company has been in business since 1959 and still isn't profitable...
4. Innovus should be renamed Infamous as in, it will be become "infamous" and terrible how our investment money was stolen and they never turned a profit and then went either out of business or "dormant" like OVIT.
5. At the very least, Innovous Pharmaceuticals, should be renamed as Innovous Therapeutics, or better yet, Innovous Sugar-pills.
6. Innovus needs to advertise on Google and Radio.
7. Innovous Pharmaceuticals, new corporate slogan should be
"Seeking FDA Fluticare approval since 1959."
Hi-tech Akorn is the Fluticare manufacturer, proof;
GTTTR15, .10 cents per post would be a dollar a day. I don't care what you think of me. I wanted Fluti and INNV to win!
GTTTR15, Hi-tech Akorn is the Fluticare manufacture, didn't you see the post from numbers, that I reposted?
Lol, I'm not on a high horse, just frustrated with going broke with INNV.
Healthywelth, my point with the 4yr old article was that Dr.Damaj had a failed product (zyoptic) that he had to remove, so what's to prevent that from happening to other products. (Duh!, can't you read between the lines healthywelth, just how dense are you, geez!??)
Also, more importantly in the article he wanted to be profitable and uplist to the NASDAQ 3 years ago!
Dr.Damaj expected to be profitable 3 years ago!
Dr.Damaj expected Fluticare to be approved way back in 2015!
Dr.Damaj is a bad judge of timing and profitability!
INNV needs to advertise on Google and radio, now Honeycomb777 go make it happen!!!
Hi-tech Akorn is the Fluticare manufacturer, now go find out when the FDA will approve it!
Syd from the Ymb was wrong;
The Fluticare manufacturer name was revealed in this Dr.Damaj interview; It's Hi-tech Akorn, not Hikma Pharmaceutical (and its U.S. subsidiary West-Ward Pharmaceutical.) Sorry Syd, you were wrong!
Watch video, Fluti manufacturer named;
Fluti follow up post;
numbersarefun Tuesday, 04/25/17 06:51:50 PM
Re: gi197845 post# 8146
Post # of 8157
gi197845, Damaj Video which mentions Hi-tech Akorn. I got a little confused in my last post. I meant Hi-tech Akorn, not Apotex. Both start with the same first letter. Akorn owns Hi-tech. Apotex is already approved, so it is most likely not Apotex.
I will repost my post #6260:
Transcribed from the video from 3:03 to 3:27:
The most sold form of fluticasone in the U.S. is not Flonase. It is actually Fluticare that is sold by Hi-Tech and Akorn. And we were actually vely lucky (Indian accent of very) to be able to have the OTC actually rights to Fluticare. As you know, the FDA recently announced the switch of fluticasone from RX to OTC.
CEOLIVE.TV Interview | Dr. Bassam Damaj / CEO of Innovus Pharmaceuticals (OTCQB: INNV)
Published on Apr 2, 2015, video length 10:02.
Start at time 3:03 out of 10:02.
More and more, I'm wondering if no manufacturer of Fluti ever submitted an(A)NDA on behalf of Novalare/INNV, since it's taking so long...It's also doubtful that any European request for Fluti approval was ever submitted either.
GTTTR15, the comment about Apotex was from; numbersarefun
post# 8077
"West-ward OTC fluticasone approved and most likely not the partner. User GT???? already said that Perrigo launched product based on the west-ward ANDA. GT is probably wrong that West-ward has another ANDA filed. No need for another ANDA since many companies have licensed and launched products based on the one ANDA by West-ward. If Innovous did not have a contract, it probably could have licensed one of the approved OTC ANDAs by Apotex or West-ward. The are two other companies with RX ANDAs.
In one of the Damaj's videos from 2015, he mentions Hi-tech Apotex as the company. He said Innovous was velly lucky (Indian accent) to get the rights to Fluticare by Hi-tech Apotex. In newer videos, he said he can not disclose the manufacturer."
I put it in quotes for you wouldn't accuse me of plagiarizing like the fool you are. Now you'll probably accuse me of libel or slander. I guess since you're such an idiot, it doesn't matter what you think.
GTTRR15, I would never argue with a fool like you, because you'd try to drag me down to your level and then beat me with experience.
ShawnP123, I guess it really doesn't matter what manufacturer it was, Apotex or Westward. I guess like you said, what matters is that the (A)NDA or whatever the heck it is was actually filed, because like you've said there does appear to be some sort of mix up, or some type of fabrication of lies, or omission/silence of the truth.
However, the reason I mentioned Apotex, is because another poster on here indicated that they recently received Fluticare approval from RX cream or something, which if true, could mean that Fluti OTC spray approval is near.
Someone here proved Apotex was announced in a 2014 presentation by Dr.Damage himself as the manufacturer of Fluti and submitter of the (A)NDA application and that in subsequent presentations, Dr.Damage refused to comment on who the Fluti manufacturer would be.
What happened to this INNV product?
http://www.news-medical.net/news/20130520/Patient-compliance-an-interview-with-Dr-Bassam-Damaj-CEO-of-Innovus-Pharma.aspx
Was "zyoptic" not a good seller?
LOL, Batermere, I know that OVIT was a terrible train wreck, I lost my life's savings in OVIT, due to Dr.Weiss. I know I've been negative about INNV today, but I am obviously frustrated...I hope and pray that INNV does well, I even ordered Vessle, it might be in my mailbox as we speak, I will have to go check...
You have to admit, my negativity might be overboard, but I did make some points that have some validity. As you know, I also like to make people laugh, so I'm glad you saw the humor in some of my posts.
I sure as hell wish Dr.Damaj would advertise on Google, wtf is his problem?
Do I have pay Google myself to get listed in its' search engine? If so, that would probably boost the share price more than me buying more INNV shares or more INNV products, because it would get others to but INNVs products.
I hate over promising and under delivering! I hate overly-positive fakeness!
This site needs to be updated and here's what need to be changed;
1. Rewrite the blurb about Dr.Damaj taking Apricus Biosciences from $.19 to $6.00 a shares as "Damaj kept doing reverse splits to get Apricus Biosciences uplisted to the NASDAQ, thereby bankrupting Apricus Biosciences and its' investors.
2. Remove Robert Hoffman from the list employees, indicating that Hoffman left due to him quickly realizing that INNV was another term for the "Titanic of companies."
3. Remove fluticare or at least tell the truth about it as in...fluticare didn't sell $1billion units itself. The $1billion in sales was actually due to the active ingredient (Fluticasone Propionate) that's in all of theses products of combined sales, Clarispray and Flonase, etc.
4. Detail how Dr.Damaj claimed Fluticare would be approved in 2015, then 2016, then 2017 and now he wouldn't even acknowledge any proof of Fluti's existence, or ANDA, or NDA, or manufacture...
5. Detail how Dr.Damaj has been over promising and under delivering.
6. Detail how Damaj is paying himself interest, thereby screwing over us "investors."
7. Detail how Dr.Damaj is so incompetent, that he doesn't know how to make INNV or its' products appear in Google searching.
8. Detail how Dr.Damaj gave away prematurely gave away half of INNV shares, well before any alleged fluticare approval.
9. Detail how Dr.Damaj added millions more diluted shares of INNV for .15.
Damaj wanted NASDAQ listing in 2014...Here's the article;
http://www.news-medical.net/news/20130520/Patient-compliance-an-interview-with-Dr-Bassam-Damaj-CEO-of-Innovus-Pharma.aspx
It looks like the Zytopic product he spoke of is discontinued. Could that same thing happen with fluti? Is Damaj headed for another dilution and a back door escape? Is Dr.Weiss of OVIT and Dr.Damaj of INNV the same person, or are they in cahoots together, on a tropical island, with our stolen investment money?
LOL @ Hairy Bumm!!!